Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A large study reveals no association between APOE and Parkinson's disease.

Federoff M, Jimenez-Rolando B, Nalls MA, Singleton AB.

Neurobiol Dis. 2012 May;46(2):389-92. doi: 10.1016/j.nbd.2012.02.002. Epub 2012 Feb 12.

2.

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA, Sawcer SJ, Barker RA.

J Neurol. 2009 Mar;256(3):493-8. doi: 10.1007/s00415-009-0119-8. Epub 2009 Mar 18.

PMID:
19308307
3.

The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.

PMID:
17689519
4.

Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.

Feldman B, Chapman J, Korczyn AD.

Acta Neurol Scand. 2006 Jan;113(1):14-7.

PMID:
16367893
5.

ApoE alleles, depression and positive affect in multiple sclerosis.

Julian LJ, Vella L, Frankel D, Minden SL, Oksenberg JR, Mohr DC.

Mult Scler. 2009 Mar;15(3):311-5. doi: 10.1177/1352458508099478.

6.

Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.

Monsell SE, Besser LM, Heller KB, Checkoway H, Litvan I, Kukull WA.

Parkinsonism Relat Disord. 2014 May;20(5):503-7. doi: 10.1016/j.parkreldis.2014.02.001. Epub 2014 Feb 13.

7.

A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease.

Multhammer M, Michels A, Zintl M, Mendoza MC, Klünemann HH.

Acta Neurol Belg. 2014 Mar;114(1):25-31. doi: 10.1007/s13760-013-0223-5. Epub 2013 Jun 21.

PMID:
23794363
8.

Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.

Blázquez L, Otaegui D, Sáenz A, Paisán-Ruiz C, Emparanza JI, Ruiz-Martinez J, Moreno F, Martí-Massó JF, López de Munain A.

Neurosci Lett. 2006 Oct 9;406(3):235-9. Epub 2006 Aug 14.

PMID:
16904828
9.

APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.

Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson’s Disease Study Group.

J Neural Transm (Vienna). 2011 Sep;118(9):1335-44. doi: 10.1007/s00702-011-0612-y. Epub 2011 Mar 1.

PMID:
21360299
10.

Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds.

Lemmens R, Görner A, Schrooten M, Thijs V.

Stroke. 2007 Apr;38(4):1185-8. Epub 2007 Feb 22.

11.

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.

Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, Jimenez-Conde J, Hansen BM, Fernandez-Cadenas I, Cortellini L, Ayres A, Schwab K, Juchniewicz K, Urbanik A, Rost NS, Viswanathan A, Seifert-Held T, Stoegerer EM, Tomás M, Rabionet R, Estivill X, Brown DL, Silliman SL, Selim M, Worrall BB, Meschia JF, Montaner J, Lindgren A, Roquer J, Schmidt R, Greenberg SM, Slowik A, Broderick JP, Woo D, Rosand J; International Stroke Genetics Consortium.

Ann Neurol. 2010 Dec;68(6):934-43. doi: 10.1002/ana.22134.

12.

Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population.

López M, Guerrero J, Yescas P, Boll MC, Familiar I, Ochoa A, Rasmussen A, Alonso ME.

Mov Disord. 2007 Feb 15;22(3):417-20.

PMID:
17230455
13.

Apolipoprotein E gene and age-related macular degeneration in a Chinese population.

Sun E, Lim A, Liu X, Snellingen T, Wang N, Liu N.

Mol Vis. 2011 Apr 20;17:997-1002.

14.

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO.

BMC Neurol. 2008 Apr 16;8:9. doi: 10.1186/1471-2377-8-9.

15.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

16.

Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.

Hostage CA, Roy Choudhury K, Doraiswamy PM, Petrella JR; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2013;8(2):e54483. doi: 10.1371/journal.pone.0054483. Epub 2013 Feb 6.

17.

Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.

Drigalenko E, Poduslo S, Elston R.

Neurology. 1998 Jul;51(1):131-5.

PMID:
9674791
18.

Apolipoprotein epsilon4 allele is associated with psoriasis severity.

Coto-Segura P, Coto E, Alvarez V, Morales B, Soto-Sánchez J, Corao AI, Santos-Juanes J.

Arch Dermatol Res. 2010 Mar;302(2):145-9. doi: 10.1007/s00403-009-1002-2.

PMID:
19911187
19.

Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.

Alexopoulos P, Richter-Schmidinger T, Horn M, Maus S, Reichel M, Sidiropoulos C, Rhein C, Lewczuk P, Doerfler A, Kornhuber J.

J Alzheimers Dis. 2011;26(2):207-10. doi: 10.3233/JAD-2011-110356.

PMID:
21606569
20.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk